SCHEMBL23917241

SCHEMBL23917241

CC(=O)c1cccc(-c2n[nH]c3ncnc(N)c23)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.57
PIK3CA P42336 4/20 0.57
PIK3CB P42338 4/20 0.57
PIK3CG P48736 4/20 0.57
PRKDC P78527 4/20 0.57
KDR P35968 3/20 0.57
SRC P12931 3/20 0.57
ABL1 P00519 2/20 0.57
EGFR P00533 2/20 0.57
HCK P08631 2/20 0.57
MTOR P42345 2/20 0.57
EPHB4 P54760 2/20 0.57
PI4KB Q9UBF8 2/20 0.57
MAP2K4 P45985 3/20 0.44
TTK P33981 2/20 0.44
MAP4K4 O95819 3/20 0.43
LRRK2 Q5S007 2/20 0.43
MAPK8 P45983 2/20 0.43
PLK4 O00444 1/20 0.43
DCLK1 O15075 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917237 0.89 MAP2K4 (0.57) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL22276018 0.82 LRRK2 (0.55) KDRMAP4K4LRRK2MAPK8CSNK2A1
SCHEMBL30386858 0.80 PIK3CD (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL11405 0.80 PIK3CG (0.61) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL19507717 0.80 CDC7 (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30387156 0.80 PIK3CD (0.59) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL20093467 0.79 JAK2 (0.52) PIK3CDPIK3CAKDRABL1MTOR
SCHEMBL19507770 0.79 EGFR (0.47) ABL1EGFRMAP4K4ROCK2CDK1
SCHEMBL20793723 0.78 FAAH (0.40) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL10855 0.78 MAP4K4 (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317140-A1 Heterocyclic Compounds and Methods of Use MEDIVATION TECHNOLOGIES, INC. (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317140-A1 Heterocyclic Compounds and Methods of Use BTK, PIK3CD, PIK3CB PIK3CD 2/4885PIK3CA 6/4885PIK3CB 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.